drugset / Trial / NCT04998071
Posterior Quadratus Lumborum Block Using 0.125% Versus 0.25% Bupivacaine for Analgesia in Children Undergoing LPEC
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The aim of the present study is to evaluate and compare the analgesic efficiency of the difference concentration between 0.125% and 0.25% bupivacaine provided by ultrasound guided posterior quadratus lumborum block undergoing LPEC in children
Timeline
- Start
- 2021-08-15
- Primary completion
- 2022-05-31
- Completion
- 2022-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bupivacaine | Other / unclassified | 0.125 % | — |
| Comparator | Bupivacaine | Other / unclassified | 0.25 % | — |
Indications
No indication recorded.